United States Antimony Corp
UAMY NYSE Primary Smelting & Refining Of Nonferrous Metals Financials FY2016βFY2025
What United States Antimony Corp does
No business description yet.
- Legal name
- UNITED STATES ANTIMONY CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 19, 2026
- Accession Β· CIK
- 0001104659-26-032049
0000101538
Revenue and margins
United States Antimony Corp had $39.3M of revenue in fiscal 2025, up 162.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$37.5M in fiscal 2025, β95.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
United States Antimony Corp returned $0.4M to shareholders in fiscal 2025. The diluted share count rose 13.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably United States Antimony Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $21.4M | $19.1M | $18.1M | $18.2M | $30.5M |
| Debt incl. finance leases | $0.2M | $0.2M | $0.0M | $0.3M | $0.2M |
| Net debt / EBITDA | β95.9x | β15.0x | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β120.1x | 23.1x | β | β | β |
| Current ratio | 11.4x | 9.7x | 15.7x | 5.2x | 5.4x |
| Quick ratio | 10.9x | 9.1x | 14.1x | 4.9x | 4.1x |
| Total assets | $35.0M | $34.7M | $28.1M | $34.6M | $154M |
| Total liabilities | $2.6M | $2.8M | $2.6M | $6.0M | $13.0M |
| Shareholders' equity | $32.4M | $31.9M | $25.5M | $28.6M | $141M |
| Net debt (β = net cash) | β$21.2M | β$18.8M | β$18.1M | β$17.8M | β$30.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 4 / 9 | 3 / 9 | 5 / 9 | 4 / 8 | 4 / 8 | 3 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β9.8% | β10.6% | 8.8% | β23.4% | β14.7% | 9.8% | 1.9% | β5.1% | β12.6% | 5.7% |
| Altman Z'' | β3.75 | β4.73 | β3.21 | β8.42 | β9.76 | 13.76 | 12.45 | 7.22 | 3.79 | 11.98 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.9M | $10.2M | $9.0M | $8.3M | $5.2M | $7.7M | $11.0M | $8.7M | $14.9M | $39.3M |
| Provision for credit losses | β | β | β | β | β | β | β | β$0.2M | β$0.3M | β$0.0M |
| Gross profit | $0.5M | $0.3M | $0.0M | β$0.8M | $0.2M | $0.8M | $2.0M | β$3.3M | $3.5M | $9.9M |
| Operating income | β$0.8M | β$1.0M | $0.5M | β$3.8M | β$3.3M | β$0.7M | $0.3M | β$7.1M | β$2.4M | β$8.5M |
| Interest expense | $0.2M | $0.1M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | β | β | β |
| Pretax income | β$1.0M | β$1.1M | $0.5M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.3M | β$1.7M | β$4.3M |
| Income tax | $0.3M | $0.0M | β$0.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$1.3M | β$1.1M | $0.9M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.3M | β$1.7M | β$4.3M |
| Net income to common | β$1.4M | β$1.2M | $0.8M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.4M | β$1.7M | β$4.3M |
| Diluted EPS | β$0.02 | β$0.02 | $0.01 | β$0.05 | β$0.05 | β | β | β$0.06 | β$0.02 | β$0.04 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | β | 0.11B | 0.11B | 0.11B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $0.4M | $0.7M | β$0.7M | β$0.0M | β$1.3M | β$2.4M | β$0.2M | β$4.8M | $2.2M | β$9.7M |
| Capital expenditure | $0.6M | $0.4M | $0.9M | $0.8M | $0.2M | $0.6M | $1.7M | $1.5M | $0.4M | $27.8M |
| Free cash flow | β$0.2M | $0.4M | β$1.6M | β$0.8M | β$1.5M | β$3.1M | β$2.0M | β$6.3M | $1.8M | β$37.5M |
| Depreciation and amortization | $1.0M | $1.0M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $1.0M | $1.1M | $1.2M |
| Stock-based compensation | $0.1M | $0.2M | $0.2M | $0.2M | $0.1M | $0.1M | β | $0.0M | $0.6M | $7.1M |
| Share buybacks | β | β | β | β | β | $0.0M | $0.2M | $0.0M | β | $0.4M |
| Dividends paid | β | β | β | β | β | β | $0.0M | $0.8M | $0.0M | β |
| Dividends and buybacks | β | β | β | β | β | $0.0M | $0.2M | $0.8M | $0.0M | $0.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.0M | $0.0M | $0.1M | $0.2M | $0.7M | $21.4M | $19.1M | $18.1M | $18.2M | $30.5M |
| Total debt | $1.9M | $1.8M | $1.7M | $0.1M | $0.1M | $0.2M | $0.2M | $0.0M | $0.3M | $0.2M |
| Current assets | $1.7M | $1.6M | $1.9M | $1.3M | $1.8M | $23.6M | $21.6M | $14.1M | $20.7M | $54.7M |
| Current liabilities | $3.4M | $3.9M | $3.5M | $4.0M | $4.5M | $2.1M | $2.2M | $0.9M | $4.0M | $10.2M |
| Inventory | $0.9M | $0.9M | $0.8M | $0.6M | $0.7M | $1.1M | $1.4M | $1.4M | $1.2M | $12.5M |
| Property and equipment, net | $15.7M | $15.1M | $15.2M | $12.2M | $11.2M | $11.1M | $12.1M | $13.5M | $12.9M | $42.4M |
| Total assets | $17.8M | $17.1M | $17.6M | $13.7M | $13.3M | $35.0M | $34.7M | $28.1M | $34.6M | $154M |
| Total liabilities | $6.4M | $6.8M | $6.1M | $5.2M | $6.1M | $2.6M | $2.8M | $2.6M | $6.0M | $13.0M |
| Preferred stock | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Shareholders' equity | $11.3M | $10.4M | $11.4M | $8.5M | $7.2M | $32.4M | $31.9M | $25.5M | $28.6M | $141M |
| Margins | ||||||||||
| Gross margin | 4.5% | 2.7% | 0.0% | β9.9% | 3.9% | 10.8% | 18.1% | β38.5% | 23.2% | 25.2% |
| Operating margin | β6.9% | β9.4% | 6.1% | β45.4% | β63.1% | β8.5% | 3.2% | β81.3% | β16.0% | β21.5% |
| EBITDA margin | 1.5% | 0.1% | 16.1% | β34.6% | β46.2% | 2.8% | 11.4% | β70.3% | β8.7% | β18.6% |
| Net margin | β11.0% | β11.1% | 9.7% | β44.4% | β62.8% | β0.8% | 3.9% | β73.0% | β11.6% | β11.1% |
| FCF margin | β1.4% | 3.4% | β17.2% | β9.7% | β29.6% | β39.7% | β17.9% | β72.2% | 12.0% | β95.5% |
| Returns | ||||||||||
| Return on capital | β4.9% | β6.2% | 4.2% | β35.2% | β39.9% | β4.7% | 2.6% | β75.1% | β17.6% | β6.0% |
| Return on capital employed | β5.7% | β7.3% | 3.9% | β38.6% | β37.5% | β2.0% | 1.1% | β26.0% | β7.8% | β5.9% |
| Return on equity | β11.5% | β10.4% | 8.0% | β36.9% | β42.0% | β0.3% | 1.3% | β22.1% | β6.4% | β5.1% |
| Return on assets | β7.4% | β6.5% | 5.0% | β23.5% | β24.4% | β0.3% | 1.2% | β20.2% | β5.5% | β4.6% |
| Return on tangible equity | β12.0% | β11.4% | 7.2% | β44.0% | β46.4% | β0.3% | 1.2% | β24.9% | β6.1% | β3.1% |
| Growth | ||||||||||
| Revenue growth | β | β14.0% | β11.7% | β8.5% | β36.7% | 48.0% | 42.6% | β21.3% | 71.8% | 162.8% |
| Net income growth | β | β | β | β520.6% | β | β | β | β1,580.8% | β | β |
| EPS growth | β | β | β | β600.0% | β | β | β | β | β | β |
| FCF growth | β | β | β542.8% | β | β | β | β | β | β | β2,195.3% |
| Share count change | β | 0.9% | 1.0% | 1.3% | 5.1% | β | β | 1.2% | 1.0% | 13.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 10.1x | 191.1x | 1.2x | β | β | β95.9x | β15.0x | β | β | β |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β5.1x | β9.0x | 5.5x | β47.9x | β183.6x | β120.1x | 23.1x | β | β | β |
| Current ratio | 0.5x | 0.4x | 0.5x | 0.3x | 0.4x | 11.4x | 9.7x | 15.7x | 5.2x | 5.4x |
| Quick ratio | 0.2x | 0.2x | 0.3x | 0.2x | 0.3x | 10.9x | 9.1x | 14.1x | 4.9x | 4.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.0% | 3.6% | 10.0% | 9.6% | 4.6% | 8.4% | 15.6% | 17.6% | 2.9% | 70.8% |
| Stock comp / revenue | 1.2% | 1.7% | 1.9% | 2.1% | 2.5% | 1.4% | β | 0.0% | 3.8% | 18.0% |
| Payouts / FCF | β | β | β | β | β | β | β | β | 0.0% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 3.0 | 5.0 | 4.0 | 4.0 | 3.0 | 5.0 | 4.0 |
| Altman Z'' | β3.7 | β4.7 | β3.2 | β8.4 | β9.8 | 13.8 | 12.4 | 7.2 | 3.8 | 12.0 |
| Accruals ratio | β9.8% | β10.6% | 8.8% | β23.4% | β14.7% | 9.8% | 1.9% | β5.1% | β12.6% | 5.7% |
Source: SEC EDGAR XBRL filings (CIK 0000101538). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.